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Abbreviations
ATM Ataxia telangiectasia mutated-protein
ATP adenosine triphosphate
CARD caspase recruitment domain
C-terminal carboxy-terminal
DD death domain
DED death effector domain
DFMO a-difluoromethylornithine
ER Estrogen/Oestrogen receptor
FACS fluorescence activated cell sorting
GFP Green fluorescent protein
IL Interleukin
IR ionising radiation
kDa kilodalton
Ldh-A Lactate dehydrogenase A
N-terminal amino-terminal
Odc Ornithine decarboxylase
PARP Poly(ADP-ribose) polymerase
PI(3)K Phosphoinositide 3-kinase
PKC Protein kinase C
Rb Retinoblastoma protein
RFC Replication factor C
snRNP small nuclear ribonucleoprotein
TAD transactivation domain
TNFR Tumour necrosis factor receptor
TUNEL terminal deoxynucleotidyltransferase-mediated uridine
triphosphate end labelling
Z-DEVD-fmk N-benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl-ketone
Z-VAD-fmk N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl-ketone
DYm mitochondrial transmembrane potential
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A.  Abstract
Apoptosis is a genetically programmed mechanism for a cell to commit
suicide.  It is needed during embryogenesis and metamorphosis, removal
of cancerous or virally infected cells, and also in maintenance of adult
tissue homeostasis.  A family of cysteine proteases, caspases, are
important mediators of apoptotic processes caused by various inducers.
They amplify the apoptotic signal and proteolytically process numerous
cellular target molecules with different functions.  This together with other
events lead into regulatory and structural changes in the cell and eventually
into the proper removal of the remnants of the apoptotic cell by the
neighbouring phagocytic cells.
The present study concentrates on the molecular mechanisms of apoptosis
induced by c-Myc transcription factor.  Especially, the involvement of
caspases in the process was studied.  The major finding of the study is that
caspases are activated during and required for c-Myc-induced apoptosis in
rat fibroblasts.  Specifically, caspases-3, -7, -8, and -9 become proteolysed/
activated during the process.  If the activity of the caspases is inhibited, the
cells are unable to undergo apoptosis.  Also, numerous previously known
substrates of caspases are cleaved in a caspase-specific manner.
Additionally, it was found out that ATM (Ataxia telangiectasia mutated) -
protein is proteolytically processed during apoptosis by c-Myc.  This
processing can be prevented by the inhibition of caspase activity,
demonstrating that ATM is a substrate of caspases.  In vitro, we found that
ATM can be cleaved by caspases-3 and -7, but not by caspases-6 or -8.
To elucidate the mechanisms of caspase activation, the involvement of the
cell surface death receptor TNFR (tumour necrosis factor receptor) was
studied.  The results show that TNFR-activation by ligand binding is not
required to transmit the apoptotic signal from c-Myc to the level of caspase
activation in rat fibroblast cells.
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B.  Review of the literature
B.1.  Apoptosis
The concept of apoptotic cell death was first introduced in 1972 when Kerr,
Wyllie and Currie (Kerr et al. 1972) noticed that cells can die in two different
ways, namely by necrosis or by apoptosis.  These two processes of cell
death differ both in the mechanism of death and in the consequences to the
surrounding tissue and the organism.  Necrosis usually follows
physiological damage to cells.  The cells suffer from such a violent trauma
that the cell swells and bursts releasing the cell contents to the
surroundings.  The exposed cellular contents cause an inflammatory
reaction in which phagocytic cells are attracted to the site to phagocytose
the debris.  In contrast to necrosis, apoptosis or programmed cell death is a
genetically determined, appropriate response to a variety of signals which
command a cell to die in an orderly fashion.  Once an apoptotic signal is
received, the cell starts to prepare itself for the destruction: the chromatin
starts condensing, cellular proteins are destroyed, and changes in the
structure of the nucleus, cytoplasm, and plasma membrane occur.
Eventually apoptotic bodies, vesicles containing the organelles and other
remnants of the cell surrounded by plasma membrane, get released into
the surroundings.  These vesicles are finally recognised and engulfed by
the neighbouring phagocytic cells without any inflammatory reaction.
Evolutionarily, apoptosis is an old method for getting rid of unwanted cells.
It can be observed in animals, plants, fungus (Podospora), conditional
multicellular organisms (Dictyostelium) and even in unicellular organisms
(Saccharomyces, Tetrahymena, Trypanosoma) (reviewed in Ameisen
1996).  In multicellular organisms apoptosis occurs in development during
embryogenesis and morphogenesis, in removal of infected or cancerous
cells, and in the maintenance of homeostasis of an adult organism.
B.2.  Caspases
The present knowledge on apoptosis and caspases has been greatly
enhanced by studies on the nematode worm C.elegans in which the first
caspase (Ced-3) was identified (Yuan et al. 1993).  During the development
of C.elegans, a specifically defined set of cells dies due to apoptosis in
order to yield a normal adult worm.  These cells do not die without the
function of the ced-3 gene.  Consequently, the previously identified
mammalian Interleukin-1b converting enzyme (ICE/caspase-1, Cerretti et
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al. 1992; Thornberry et al. 1992) was noticed to be a homologue of Ced-3.
Currently, fourteen mammalian homologues of Ced-3 have been cloned,
characterised, and named caspases 1 to 14 (Figure 1).  Phylogenetically
they can be divided into two subgroups, one comprising of caspases
involved in apoptosis (caspases-2, -3, -6, -7, -8, -9, and -10) and the other
including the ICE-like caspases (caspases-1, -4, -5, -11, -12, -13, and -14).
It is likely that the ICE-like caspases are primarily involved in procytokine
activation instead of being active components of apoptotic processes.
Figure 1.  The phylogenetic tree of
fourteen mammalian caspases
(Adapted from Humke et al. 1998;
Nicholson 1999; Thornberry and
Lazebnik 1998).  The old
nomenclature of caspases is in
parenthesis.  References for
caspases: 1: Cerretti et al. 1992;
Thornberry et al. 1992, 2: Kumar et
al. 1994; Wang et al. 1994, 3: 
Fernandes-Alnemri et al. 1994;
Nicholson et al. 1995; Tewari et al.
1995, 4: Faucheu et al. 1995;
Kamens et al. 1995; Munday et al.
1995, 5: Munday et al. 1995, 6: 
Fernandes-Alnemri et al. 1995a, 7: Duan et al. 1996a; Fernandes-Alnemri et al. 1995b;
Lippke et al. 1996, 8: Boldin et al. 1996; Fernandes-Alnemri et al. 1996; Muzio et al. 1996, 9: 
Duan et al. 1996b; Li et al. 1997b; Srinivasula et al. 1996, 10: Fernandes-Alnemri et al.
1996; Vincenz and Dixit 1997, 11: Van de Craen et al. 1997; Wang et al. 1996, 12: Van de
Craen et al. 1997; 13: Humke et al. 1998, 14: Ahmad et al. 1998; Hu et al. 1998a.
B.2.1.  Structure and function of caspases
Caspases are aspartic acid-specific cysteine proteases, which become
activated in most forms of apoptosis.  In cells, they localise in nucleus,
cytoplasm, and mitochondrial intermembrane space, and can also be
translocated to the plasma membrane receptors via adapter proteins
(Boldin et al. 1996; Colussi et al. 1998; Mancini et al. 1998; Muzio et al.
1996; Thornberry et al. 1992).  Caspases are expressed in most tissues in
an inactive pro-form, which has an amino-terminal prodomain, a large
subunit (~20 kDa) and a small subunit (~10 kDa) (Figure 2A).  Upon
activation, a procaspase is proteolytically cleaved to remove the pro-
domain and to release the large and the small subunit (Thornberry et al.
1992).  Two small and two large subunits are assembled together to yield
an active caspase enzyme with two active sites (Figure 2B, Rotonda et al.
1996; Walker et al.  1994 ;  Wilson  et  al.  1994 ).    The  active  site  has  a
3    (CPP32, Yama, apopain, prlICE)
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Figure 2. A. Schematic presentation of
the general structure of caspases.  DED =
Death Effector Domain (dotted), QACQG
= consensus amino acid sequence of the
active site of caspases (black ellipses) in
large subunit, arrows = sites of
processing to release large subunit (light
grey) and small subunit (dark grey) from
prodomain (white).  B. Active caspase
tetramer.
consensus sequence QAC(R/Q)G in the structure of the large subunit, the
cysteine moiety being essential for the enzymatic activity (Thornberry et al.
1992; Walker et al. 1994; Wilson et al. 1994).  However, amino acids from
both the large and the small subunit are needed for the activity.
In their substrates, caspases identify a four amino acid recognition
sequence where an essential aspartic acid determines the site of cleavage
(Howard et al. 1991; Rano et al. 1997; Sleath et al. 1990; Thornberry et
al.1997).  Given the shortness of the recognition sequence, additional,
currently unknown factors (possibly the tertiary structure of the substrate
around the cleavage site) must further determine the specificity of the
caspase cleavage, as only some and not all proteins with the recognition
sequences become processed by caspases.  The cleavage of vital cellular
proteins by caspases is thought to affect the cellular homeostasis and
eventually lead into the destruction of the cell.
Though caspases have been shown to be activated in almost all forms of
cell death, it seems likely that caspase activity is not the only factor
contributing to cell death.  In some cases caspases can become active in
non-apoptotic situations.  Apparently T lymphocyte activation and terminal
differentiation of rodent lens epithelial cells involve activation of caspase-3
without associated apoptosis (Ishizaki et al. 1998; Miossec et al. 1997).
B.2.2.  Substrates of caspases
The substrates of caspases are numerous and heterogeneous (reviewed in
Stroh and Schulze-Osthoff 1998).  They can be divided roughly in three
subgroups: 1) structural proteins (e.g. lamins and actin), 2) regulatory
proteins involved in signal transduction and cell cycle progression (e.g.
PKCd and Mdm-2), and 3) proteins involved in the maintenance of the
integrity of the genome, replication of DNA, and processing of mRNA
A
B
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transcripts (e.g. PARP, RFC, and 70 kDa U1 snRNP).  Thus by the
cleavage of the targets the cell prevents cell cycle progression and repair
mechanisms, starts to break down the organised structure of the cell, and
to mark the dying cell for the engulfment by phagocytosis.  The cleavage of
a substrate protein can either activate or inactivate the function of the
protein.  For example, the proteolysis of PKCd by caspase-3 yields a kinase
domain with an increased kinase activity that is able to promote apoptosis
(Emoto et al. 1995; Ghayur et al. 1996).  On the other hand, processing of
PARP by caspases cleaves off the DNA-binding domain of the protein and
thus inhibits the function of PARP in DNA repair (L zebnik et al. 1994).
Many substrates can be proteolytically processed by several caspases both
in vitro and in vivo, but for example lamins are targets for caspase-6 only
(Orth et al. 1996; Takahashi et al. 1996).
B.2.3.  Caspase knockouts
Caspase knockout mice have provided further information about the role of
particular caspases in apoptosis and development.  The targeted
disruptions of the gene coding for caspase-1 affected the processing of IL-
1b, production of IL-1a, and Fas (CD95/APO-1)-mediated apoptosis of
thymocytes, without developmental defects or impairments in the ability of
cells to undergo apoptosis induced by other factors (Kuida et al. 1995; Li et
al. 1995).  Mice devoid of functional caspase-2 develop normally and show
defects in apoptosis in female germ cell production (Bergeron et al. 1998).
Far more dramatic effects can be observed in caspase-3 knockout animals:
reduced viability, profound neurological defects, and cell- and stimulus-
dependent abnormalities in apoptotic processes (Kuida et al. 1996; Woo et
al. 1998).  Targeted disruption of the gene coding for caspase-8 causes
death in utero (Varfolomeev et al. 1998).  The absence of caspase-8
function also prevented apoptosis by the activation of several members of
the TNFR-family demonstrating the non-redundant role of caspase-8 in the
death process by TNF receptors.  Disruption of caspase-9 causes
embryonic lethality and defective brain development together with the
inhibition of apoptosis by several inducers and the processing of caspase-3
and caspase-8 (Hakem et al. 1998; Kuida et al. 1998).  A knockout animal
model has shown that murine caspase-11 is needed for the ability of
caspase-1 to cause apoptosis in mice (Wang et al. 1998).
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B.2.4.  Activation of caspases
Caspase cascade
To become enzymatically active, a caspase must be proteolytically
processed (Thornberry et al. 1992).  After a cell receives a signal for
apoptosis, a sequential activation of caspases takes place; i.e. an upstream
caspase processes and activates other caspase(s) downstream (Figure
3A).  By this method an apoptotic signal gets amplified rapidly, as
proteolytic activation of pre-existing molecules occurs instead of a much
more slowly de novo-synthesis.  The hierarchial order of caspases in the
caspase cascade is dependent on the apoptotic stimulus and cell type.    
Receptor association
The division into upstream initiator and downstream effector caspases is
reflected in their structural differences: the effector caspases (e.g.
caspases-3, -6, and -7) have a short pro-domain, while the initiator
caspases (e.g. caspases-8 and -10) have a long pro-domain containing two
death effector domains (DED).  The DEDs of initiator caspases serve as
binding motifs for association with cell surface death receptors via adapter
proteins (Boldin et al. 1996; Muzio et al. 1996).  For example, the DED of
caspase-8 mediates the binding of caspase-8 to the FADD-adapter protein
(Figure 3B, Boldin et al. 1995; Chinnaiyan et al. 1995).  FADD has another
binding motif, DD (Death Domain), which serves as a binding motif to the
DD in the Fas.  Thus the activation of Fas leads into the translocation of
caspase-8 to the cytoplasmic regions of the receptor, and presumably the
close proximity of several caspase-8 molecules causes autoactivation and
processing of the caspase-8 molecules which are then ready to activate
downstream caspases (Martin et al. 1998; Medema et al. 1997; Muzio et al.
1998; Yang et al. 1998).
Apoptosome
Similar to the activation of caspase-8 recruited to death receptors, also the
activation of caspase-9 in the cytoplasm can occur without processing by
an upstream caspase.  Instead, the activation of caspase-9 involves the
formation of the so-called apoptosome (Figure 3C).  Apoptosome is a
complex containing caspase-9, Apaf-1 (mammalian homologue of
C.elegans Ced-4), cytochrome c, and dATP (Li et al. 1997b; Zou et al.
1997).  Cytochrome c and dATP are required for the oligomerisation of two
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Figure 3.  A. Proteolytic processing and activation of downstream caspases by uptstream
caspases forms a caspase cascade, which amplifies apoptotic signal in cells.  B. Activation
of a caspase by a death receptor.  Activated, trimeric death receptor binds FADD via DD’s
(grey rectangles).  FADD binds to caspase-8 via DED’s (black rectangles), leading to
formation of an active caspase.  C. Activation of caspase-9 by apoptosome.  Inactive
apoptosome is proposed to consist of procaspase-9 (with black CARD), Apaf-1, and anti-
apoptotic Bcl-2 family member.  Additional, unknown proteins may mediate or regulate these
interactions.  Dissociation of Bcl-2 protein from the complex and association of cytochrome c
and dATP activates the apoptosome and causes proteolytic processing and activation of
caspase-9.
pro-
pro-
upstream caspase
downstream
pro-caspase
active down-
stream caspase
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or more Apaf-1 molecules (Hu et al. 1998c; Srinivasula et al. 1998; Zou et
al. 1999), and consequently the caspase recruitment domains (CARD) in
Apaf-1 and in caspase-9 mediate the association between the molecules
(Li et al. 1997b).  Analogously to the close proximity model of the activation
of caspase-8, the induced proximity of several caspase-9 molecules may
cause autoactivation of caspase-9, which then can activate downstream
caspases (Zou et al. 1997).  Interestingly, it seems that once caspase-9 is
activated, it remains associated with Apaf-1, and the enzymatic activity of
Apaf-1-bound caspase-9 is far greater than that of free caspase-9
(Rodriguez and Lazebnik 1999).
Contradictory to the current opinion on the activation of caspases via
proteolytic processing and association to yield an active tetrameric
caspase, a recent report (Stennicke et al. 1999) demonstrates that pro-
caspase-9 is enzymatically active even without proteolytic processing.  At
the moment it remains unknown whether the same applies to other
caspases too.
The close proximity mode may be utilised also in the activation of
caspases-1, -2, -4, and -10 which in their prodomain have a CARD region
which can mediate homotypic associations with other CARD proteins (for
review see Hofmann 1999).  These CARD proteins may bring together
caspases for activation or otherwise affect their function.
Mitochondrial involvement
During the past years, mitochondria have emerged as central regulators of
apoptosis.  In cell death, the so-called permeability transition pores appear
in the mitochondrial membranes.  Further, the mitochondria loose the
transmembrane potential (DYm), which is considered to be a point-of-no-
return in apoptosis (Zamzami et al. 1995b).  These mitochondrial changes
can cause leakage or translocation of mitochondrial proteins (e.g.
cytochrome c and a protease named AIF, Kluck et al. 1997; Liu et al. 1996;
Susin et al. 1996; Yang et al. 1997) into the cytoplasm.  On the other hand,
the translocation of mitochondrial proteins has been shown to occur without
a loss of the DYm (Bossy-Wetzel et al. 1998; Kluck et al. 1997; Vander
Heiden et al. 1997; Yang et al. 1997). Whilst the mitochondrial release of
cytochrome c promotes the formation of the apoptosome complex and the
subsequent activation of caspase-9, the role of mitochondria in the
activation of the other caspases remains more elusive.  Depending on the
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cell type or apoptotic inducer, activation of a particular caspase may take
place upstream or downstream of mitochondrial activity (Marchetti et al.
1996; Scaffidi et al. 1998; Zamzami et al. 1996).
Other proteins associating with caspases
In cells, the pro-caspases can associate with heat shock proteins Hsp10
and Hsp60 (Samali et al. 1999; Xanthoudakis et al. 1999).  The heat shock
proteins apparently maintain the pro-caspase in a protease-sensitive state,
and dissociate from the processed, enzymatically active caspase during
apoptosis.
B.2.5.  Inhibition of caspase activity
Viral proteins
One of the functions of apoptosis is to remove virally infected cells in an
organism.  To prevent apoptosis of a host cell, viruses encode proteins to
inhibit the activity of caspases.  For example, the cowpox virus protein
CrmA and the baculovirus protein p35 contain a caspase recognition
sequence, but instead of dissociating from these viral substrates the
caspases of the host cell remain bound to the viral protein and thus
become inactivated (Bump et al. 1995; Ray et al. 1992).
Other viral inhibitors of caspases include the FLIP (lice Inhibitory Proteins,
reviewed in Tschopp et al. 1998) and IAP (Inhibitor of Apoptosis Protein,
reviewed in Deveraux and Reed 1999) –families.  Also cellular counterparts
of these proteins have been cloned.  FLIPs contain DED-domains which
are used to interfere with the associations between the molecules of the
apoptotic machinery of the host cell.  IAPs are likely to inhibit apoptosis in
at least two ways: by directly associating with caspases and preventing
their activity, and by activating the anti-apoptotic NF-kB -signalling
pathway.
Bcl-2 family proteins
The Bcl-2 family consists of both anti- and pro-apoptotic proteins (reviewed
in Adams and Cory 1998), which in cells reside predominantly in the outer
mitochondrial membrane, endoplasmic reticulum, and the outer nuclear
envelope.  Indirectly, Bcl-2 proteins can regulate the activity of caspases by
affecting the mitochondrial events during apoptosis.  For example, the
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expression of the anti-apoptotic Bcl-2 can inhibit and the expression of the
pro-apoptotic Bax can promote the loss of DYm (Zamzami et al. 1995a;
Zamzami et al. 1995b).  Given the ability of Bcl-2 proteins to form pores on
membranes (Minn et al. 1997), it is possible that the Bcl-2 proteins regulate
the translocation of mitochondrial ions or proteins into the cytoplasm.  For
example, cytochrome c has been shown to translocate from mitochondria
into the cytoplasm, and this can be prevented by the expression of the anti-
apoptotic Bcl-2 protein (Kluck et al. 1997; Yang et al. 1997).  However, Bcl-
2 family proteins must have other functions downstream of cytochrome c in
apoptosis as Bcl-2 and Bcl-XL can prolong cell survival even if cytochrome
c is already in the cytoplasm (Li et al. 1997a; Rosse et al. 1998;
Zhivotovsky et al. 1998).
A model for the regulation of caspase activity by Bcl-2 proteins has been
proposed based on the interactions between Bcl-2, caspases, cytochrome
c, and Apaf-1 (Figure 3C, Hu et al. 1998b; Pan et al. 1998).  According to
this model, in non-apoptotic cells an anti-apoptotic Bcl-2 protein is
associated with Apaf-1 and an inactive pro-caspase-9.  This association
may be indirect and involve additional proteins (Moriishi et al. 1999).
Following the activation of apoptosis, the dissociation of Bcl-2 protein
allows the formation of oligomerised apoptosome complexes.  This would
result in activation of caspase-9 and progression on the apoptotic route.
In addition to Bcl-2 proteins affecting the activation of caspases, also the
reverse can occur.  For example, caspases-3 and -8 can proteolyse the
anti-apoptotic Bcl-2 and pro-apoptotic Bid protein, respectively, and the
resulting proteolytic fragments can induce the release of cytochrome c from
mitochondria (Kirsch et al. 1999; Li et al. 1998; Luo et al. 1998).
Post-translational modifications of caspases
Interestingly, it has recently been reported that human caspase-9 is a target
for phosphorylation (Cardone et al. 1998).  Following Ras oncogene
activation Akt kinase phosphorylates caspase-9, which renders caspase-9
inactive.  Akt does not phosphorylate caspase-3 or -8, so whether also
other caspases are targets for phosphorylation remains to be seen.  In
addition to phosphorylation, the activity of caspases can be regulated post-
translationally also by nitrosylation.  An inactive caspase-3 is nitrosylated at
the catalytic site cysteine but following an apoptotic stimulus (e.g. Fas), the
cysteine becomes denitrosylated resulting in an increased enzymatic
activity of caspase-3 (Mannick et al. 1999).
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Synthetic peptides
Synthetic peptides that contain only a short tetrapeptide recognition
sequence for the different caspases fused with a membrane permeable
agent have been used extensively to inhibit caspase activity in cells in
various experimental settings.
B.3.  c-Myc and apoptosis
B.3.1.  c-Myc
c-Myc is a member of the Myc-family of transcription factors, which also
include N-Myc, L-Myc, and the viral v-Myc proteins (Kohl et al. 1983; Nau et
al. 1985; Schwab et al. 1985; Sheiness and Bishop 1979; Sheiness et al.
1978; Vennstrom et al. 1982).  The c-myc gene is evolutionarily conserved
but absent from the genomes of yeast and C.elegans.  The human c-myc
can encode three polypeptides of molecular weights 45-50 (c-MycS,
(Spotts et al. 1997), 64, and 67 kDa, the 64-kDa protein being the major
product of the gene (Hann et al. 1988).  The 64-kDa c-Myc has several
structural and functional domains (Figure 4): the nuclear localisation signal
directs c-Myc to the nucleus (Dang and Lee 1988), the C-terminal basic-
helix-loop-helix-leucine zipper (bHLHZip) –domain is required for protein-
protein interactions and binding to DNA (Landschulz et al. 1988; Murre et
al. 1989), and the N-terminal transactivation domain (TAD) mediates the
activation of the basal transcription machinery (Kato et al. 1990).
Figure 4.  Schematic structure of c-Myc protein.  Indicated are transactivation domain (TAD,
dotted), major nuclear localisation signal (NLS, grey), and bHLHZip-domain (striped).
Shown are also evolutionarily conserved Myc-homology boxes (MBI & II, black).  c-Myc
associates with a related protein Max.
c-Myc as a transcription factor
c-Myc is a transcription factor able to either activate or repress
transcription.  The proposed target genes of c-Myc are numerous (reviewed
TAD
MBI MBII NLS b HLH Zip
b HLH Zip
Max
c-Myc
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in Cole and McMahon 1999; Dang 1999; Facchini and Penn 1998; Grandori
and Eisenman 1997), and examples of such targets include genes
encoding for Cdc25A, Ldh A, Odc and p53 (Bello-Fernandez et al. 1993;
Galaktionov et al. 1996; Reisman et al. 1993; Shim et al. 1997).  However,
it is possible that of the known potential target genes only cad, gadd45 and
cdk4 are true c-Myc targets, as only their mRNA expression is altered in c-
Myc null cells (Bush et al. 1998; Hermeking et al. 2000).
To regulate transcription, c-Myc needs to associate with another related
bHLHZip-protein called Max (Amati et al. 1993; Blackwood and Eisenman
1991; Kretzner et al. 1992).  The HLH and leucine zipper domains mediate
the association between c-Myc and Max, and the basic regions mediate the
binding of the dimer to the CA(C/T)GTG-consensus sites in DNA (Blackwell
et al. 1990; Prendergast and Ziff 1991).  Apparently c-Myc or Max
homodimers do not exist or do not function as regulators of transcription.  In
addition to c-Myc, Max has also other heterodimerisation partners, e.g. Mad
with the ability to repress transcription of genes regulated by c-Myc (Ayer et
al. 1993).
In addition to Max, a number of other proteins can associate with the
bHLHZip or TAD of c-Myc and regulate its activity (reviewed in Sakamuro
and Prendergast 1999).  Recently, TRRAP, an ATM-related protein, has
been demonstrated to associate with c-Myc (McMahon et al. 1998).
TRRAP and its yeast homologue Tra1 are components of a large
multiprotein complex called SAGA, with histone acetylase activity (Gran  et
al. 1998; Saleh et al. 1998; Vassilev et al. 1998).  As histone acetylation is
often associated with transcriptional activation, it is possible that
recruitment of the SAGA complex is the mechanism by which c-Myc
activates its target genes.
c-Myc and regulation of proliferation, differentiation, and transformation
c-Myc is one of the most important known regulators of cell cycle
progression.  Its expression alone can push quiescent cells into the DNA
synthesis phase of the cell cycle (Eilers et al. 1991).  If the expression of c-
Myc is prevented, the cells can not proceed in the cycle (Heikkila et al.
1987).  The level of c-Myc protein is low in quiescent cells, but is increased
rapidly following a mitogenic stimulus leading into re-entry into the cycle
(Kelly et al. 1983).  In cycling cells c-Myc expression remains at a constant
level, but is required to decrease to a lower level during differentiation of
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the cells (Coppola and Cole 1986), with a concomitant increase in the
expression of Mad (Ayer and Eisenman 1993).
Like many regulators of cell growth and differentiation, c-myc is an
oncogene, which together with another oncogene, e.g. ras, can transform
cells (Land et al. 1983; Schwab et al. 1985).  An altered expression of c-
Myc is observed in numerous human tumours and is believed to be
involved in the development of the tumours.  An appropriate c-Myc
expression is required during development as demonstrated by mice with
targeted disruption of the c-myc gene: the homozygous mice can not
survive beyond day 10.5 of gestation and are retarded in growth together
with several developmental abnormalities (Davis et al. 1993).
B.3.2.  Apoptosis induced by c-Myc
In addition of being a regulator of cell growth and differentiation, c-Myc can
also cause cells to undergo apoptosis.  Interestingly, both under- and
overexpression of c-Myc can be apoptotic depending on the circumstances.
For example, the ability of some lymphocytic cells to undergo apoptosis
induced by various treatments is dependent on reduction in c-Myc
expression (Fischer et al. 1994; Wang et al. 1999; Wu et al. 1996).  If the
level of c-Myc is manipulated to remain high, apoptosis can be prevented.
On the other hand, also an increased expression of c-Myc can lead cells
into the apoptotic route.  This has been shown in several cell lines including
CHO (Wurm et al. 1986), fibroblasts (Evan et al. 1992; Wyllie et al. 1987),
and myeloid 32D cells (Askew et al. 1991).  Also, apoptosis in T-cells can
be prevented by the administration of c-Myc antisense oligonucleotides (Shi
et al. 1992).
Currently, the mechanism(s) by which c-Myc induces apoptosis is elusive.
Being a transcription factor, one obvious way for c-Myc to influence the
survival of cells would be via transcriptional regulation of target genes.
Such potential target genes mediating apoptosis induced by c-Myc include
odc, ldh A, and cdc25A, as the expression of these three genes has been
shown in certain circumstances to lead into apoptosis (Galaktionov et al.
1996; Packham and Cleveland 1994; Shim et al. 1998).  However, also
other mechanisms need to be investigated, as it has been shown that c-
Myc can induce apoptosis without transcriptional activation (Evan et al.
1992).  Further, c-MycS, a shorter translational product of c-Myc which
lacks an intact N-terminal TAD, is able to induce apoptosis (Xiao et al.
1998).
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B.3.3.  Modulators of c-Myc-induced apoptosis
Akt
Akt is a serine/threonine kinase which is activated by PI(3)K involved in
signalling through many cell surface receptors.  During the past years Akt
has emerged as an important regulator of apoptosis.  Akt is able to
phosphorylate Bad and caspase-9 and thus protect cells from apoptosis
(Cardone et al. 1998; del Peso et al. 1997).  Similarly, in c-Myc-induced
apoptosis the expression of Akt can inhibit the apoptotic process
(Kauffmann-Zeh et al. 1997).  Akt is a downstream effector of insulin-like
growth factor-1 and the nerve growth factor receptor TrkA which are able to
protect cells from c-Myc-induced cell death (Harrington et al. 1994; Ulrich et
al. 1998), and thus the protective effect of these and possibly other growth
factors may be mediated by Akt.
Bcl-2-family proteins
The anti-apoptotic Bcl-2 proteins have been shown to inhibit c-Myc-induced
apoptosis in several cell types including epithelial and fibroblast cells
(Bissonnette et al. 1992; Fanidi et al. 1992; Reynolds et al. 1994;
Sakamuro et al. 1995; Wagner et al. 1993).
Fas-pathway
Recently, the relationship between c-Myc and Fas in apoptosis has been
investigated (Hueber et al. 1997; Juin et al. 1999; Rohn et al. 1998; Yeh et
al. 1998).  According to one study, if the binding of Fas ligand to the Fas
receptor and consequently the activation of Fas receptor are inhibited, the
ability of c-Myc to induce apoptosis is reduced (Hueber et al. 1997).  Also,
the expression of a dominant-negative FADD protein, which is able to block
Fas-induced apoptosis by inhibiting the activation of caspase-8 by FADD,
blocks apoptosis induced by c-Myc (Hueber et al. 1997).  These results on
the augmentation of c-Myc-induced apoptosis by Fas and FADD are,
however, contradicted by another study using FADD knockout mice
demonstrating that the function of FADD is not required for the ability of c-
Myc to induce apoptosis (Yeh et al. 1998).  Yet another study postulates
that although Fas-signalling is required for c-Myc-induced cell death, c-Myc
and FADD reside on separate apoptotic pathways (Rohn et al. 1998).
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JNK-pathway
The involvement of JNK (Jun N-terminal kinase) -pathway in c-Myc-induced
apoptosis remains problematic.  One study demonstrates increased JNK
activity and a consequent increase in the phosphorylation of c-Jun following
apoptosis induced by c-Myc (Yu et al. 1997).  However, another study
demonstrates a decrease in the phosphorylation status of c-Jun following c-
Myc-induced cell death (Klefstrom et al. 1997).
Max
The ability of c-Myc to cause apoptosis requires dimerisation with Max
(Amati et al. 1993; Bissonnette et al. 1994).  A study has revealed that the
two splice forms of Max have different effects on apoptosis in NIH3T3 and
32D cells: the short form does not affect the level of apoptosis following
growth factor removal, whilst the long form significantly accelerates
apoptosis (Zhang et al. 1997).
Odc
Ornithine decarboxylase (Odc) is an enzyme involved in the biosynthesis of
polyamines in cells.  Odc is a potential oncogene as its overexpression can
transform cells (Auvinen et al. 1992; Moshier et al. 1993).  odc is a target
gene for c-Myc (Bello-Fernandez et al. 1993) and in the IL-3-dependent
lymphoid 32D.3 cells the expression of both c-Myc and Odc have been
shown to accelerate apoptosis induced by IL-3 removal (Packham and
Cleveland 1994).  Further, inhibition of Odc activity decreased the ability of
c-Myc to cause apoptosis, implying that Odc mediates c-Myc-induced
apoptosis.  However, results obtained from experiments where the cellular
contents of polyamines (i.e. the products of polyamine biosynthesis
pathway) are directly manipulated indicate that either an increase (Hu and
Pegg 1997; Poulin et al. 1995; Tobias and Kahana 1995) or a decrease
(Brune et al. 1991; Desiderio et al. 1995; Grassilli et al. 1995) in polyamine
levels can promote apoptosis.
p53, Mdm-2, and p19Arf
p53 is a transcription factor and a tumour suppressor protein needed for
growth arrest after damage to DNA.  An increased expression of p53 can
be apoptotic (Shaw et al. 1992; Yonish-Rouach et al. 1991), though the
mechanism(s) of p53-induced cell death are not known.  It is possible that
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the protein products of the target genes of p53 (e.g. bax) are involved
(Miyashita et al. 1994; Miyashita and Reed 1995).  In several studies the
function of p53 protein has been demonstrated to be necessary for c-Myc-
induced apoptosis (Hermeking and Eick 1994; Soengas et al. 1999;
Wagner et al. 1994; Zindy et al. 1998).  However, in other cases p53 is
dispensable for the ability of c-Myc to cause cell death (Lotem and Sachs
1995; Sakamuro et al. 1995).
Two proteins, Mdm-2 and p19Arf, form a ternary complex with and regulate
the activity of p53.  Mdm-2 promotes the degradation of p53, and the
overexpression of Mdm-2 has been shown to inhibit p53-dependent
apoptosis induced by c-Myc (Yu et al. 1997).  The expression of rodent
p19Arf protein and its human homologue p14Arf induce cell cycle arrest in
cells in a p53-dependent manner and are potent tumour suppressors
(Kamijo et al. 1997; Quelle et al. 1995).  p19Arf stabilise p53 by inhibiting its
degradation by Mdm-2 (Kamijo et al. 1998; Pomerantz et al. 1998; Stott et
al. 1998).  In addition, p19Arf has been shown to mediate the p53-
dependent apoptosis induced by c-Myc (Eischen et al. 1999; Zindy et al.
1998).
Other proteins
A group of proteins has been shown to affect c-Myc-induced apoptosis
either by promoting or inhibiting the cell death by c-Myc.  Promoters or
mediators of apoptosis by c-Myc include Ldh A (Shim et al. 1998) and Pim-
1 serine/threonine kinase (Mochizuki et al. 1997). Eukaryotic translation
initiation factor 4E (Polunovsky et al. 1996) and AP-2 transcription factor
(Moser et al. 1997) are suppressors or negative regulators of Myc-induced
apoptosis.
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C.  Aims of the study
The aim of the present study was to elucidate the process of apoptosis
induced by the c-Myc oncogene by investigating the molecules and
mechanisms involved in mediating the signal from c-Myc to cell death.
Especially, experiments were conducted to study the involvement of
caspases in c-Myc-induced apoptosis.
D.  Materials and Methods
D.1.  Cell lines              Description                     Reference                     Used in
COS-7 African Green monkey ATCC III
kidney cells
HeLa human epithelioid cervixATCC I
carcinoma cells
HL-60 human myelomonocytic ATCC II
leukaemia cells
Rat 1A MycER rat fibroblasts with (Eilers et al. 1989) I
inducible c-Myc
expression
Rat 1 MycERTM rat fibroblasts with (Littlewood et al. 1995) I, II, IV
inducible c-Myc
expression
D.2.  Plasmids  Description                                Reference                     Used in
p21 human p21 cDNA Dr. Bert Vogelstein I
mouse p21 cDNA Dr. Bert Vogelstein I
rat p21 cDNA Dr. Bert Vogelstein I
pCMV53wt p53 cDNA Dr. Moshe Ohren I
pCMVbGal b-galaktosidase cDNA, Clontech III
transfection efficiency
control
pGFP-DFADD cDNA encoding aa’s 80-208 of Dr. Harald Wajant IV
human FADD protein fused with
Green Fluorescent Protein-
encoding region
pODC16 mid-coding region and 3’ non- Dr. Olli Jänne I
translated region of murine odc
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pOD CAT murine odc gene region (-2700 - (Brabant et al. 1988) III
 +2500) fused with CAT-reporter
gene
pPLCAT encoding for CAT-gene, (Palvimo et al. 1991) III
negative control
pPLODCCAT murine odc gene region (-1658 - (Palvimo et al. 1991) III
+16) fused with CAT-reporter gene
pSV2CAT encoding for CAT-gene, (Gorman et al. 1982) III
positive control
pSVDBrMax human Max cDNA with (Ayer et al. 1993) III
DNA-binding region deleted
pSV-Max human Max cDNA (Makela et al. 1992) III
pSVTc-myc human c-Myc cDNA Dr. Kari Alitalo
D.3.  Antibodies                                  Reference                     Used in
Actin (A-2668) Sigma II
ATM (AHP392) Serotech II
Bad Transduction Laboratories I
Bag-1 (C-16) Santa Cruz I
Bax (P-19) Santa Cruz I
Bcl-2 Transduction Laboratories I
Bcl-XL Transduction Laboratories I
Caspase-3/CPP32 Dr. Donald W. Nicholson I
Caspase-7 Dr. Donald W. Nicholson IV
Caspase-8 Dr. Donald W. Nicholson IV
Caspase-10 Dr. Donald W. Nicholson IV
cPLA2 (N-216) Santa Cruz II
Cyclin A (C-19) Santa Cruz I
Cyclin B UBI I
Cyclin D1 Dr. Jiri Bartek I
Cyclin E (M-20) Santa Cruz I
D4-GDI Dr. Dennis Danley II
FasL (MFL4) Pharmingen IV
Fodrin Dr. Ismo Virtanen II
Gas2 Dr. Claudio Schneider II
Gelsolin Transduction Laboratories II
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ICH-1L/caspase-2 Transduction Laboratories I
Lamin A+B2 Zymed II
Lamin B1 Zymed II
Mdm-2 (SMP14) Santa Cruz II
p21 (C-19) Santa Cruz I
p21 (M-19) Santa Cruz I
p53 (pAb122) Pharmingen II
p53 (pAb240) Pharmingen I, II
PARP (C-2-10) Dr. Guy G. Poirier I
PCNA Santa Cruz I
PKCg Gibco II
Rb (G3-245) Pharmingen II
RFC Dr. Wolfgang Schmid II
SREBP (K-10) Santa Cruz II
TNF (G281-2626) Pharmingen IV
TNF (MP6-XT3) Pharmingen IV
U1-70 kDa Dr. Anthony Rosen II
D.4.  Methods                                                                      Used in
Cell culture I, II, III, IV
Transfection of cells I, III
RT-PCR (reverse-transcription polymerase chain reaction) I
Northern blot I, III
Western blot I, II, IV
Immunofluorescence microscopy I, III
Assay of Odc activity I
Assays of cell death
DNA-ladder analysis I
DAPI/Hoechst I, III
Trypan blue exclusion I, IV
TUNEL I
AnnexinV + Propidium iodide -binding assay I
Measurement of mitochondrial transmembrane potential II
CAT (chloramphenicol acetyltransferase)-assay III
Thin layer chromatography III
Assay of enzymatic activity of caspases IV
Inhibition of caspase activity IV
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E.  Results and discussion
To study the mechanisms of c-Myc-induced apoptosis, Rat-1 MycER
fibroblast cell lines with an inducible c-Myc activity were used (Evan et al.
1992; Littlewood et al. 1995).  These cells express constitutively a fusion
protein in which the c-Myc cDNA has been fused with the coding region of
oestrogen receptor (Eilers et al. 1989).  The addition of oestrogen
analogues b-estradiol or 4-hydroxytamoxifen causes a conformational
change in the fusion protein and induces the c-Myc activity.  If the activity of
c-Myc is induced in low serum conditions, the cells die due to apoptosis
(Evan et al. 1992; Littlewood et al. 1995).
E.1.  Caspases in c-Myc-induced apoptosis
To find out if caspases were necessary in mediating the apoptotic effect of
c-Myc, Z-VAD-fmk, a broad-spectrum inhibitor able to impair the activity of
all caspases was used. Rat-1A MycER cells were treated or not with Z-
VAD-fmk followed by the induction of the activity of c-Myc and apoptosis.
As depicted in Fig. 8A in I, the treatment of cells with Z-VAD-fmk rescued
cells from c-Myc-induced apoptosis in a concentration dependent manner.
Another inhibitor, Z-DEVD-fmk, selectively inhibits the activity of the
caspase-3-like subgroup.  Figure 8B in I shows that the administration of Z-
DEVD-fmk reduced the level of cell death by c-Myc.  Hence it was possible
to conclude that in c-Myc-induced apoptosis caspases are needed for cell
death, and that it would be likely that member(s) of the caspase-3-like
subgroup of caspases would be involved.
Next, the identity of caspases involved in c-Myc-induced apoptosis was
studied.  The activation of caspases requires the specific proteolytic
processing of the caspase molecules to yield the small and the large
subunits which are assembled into an enzymatically active enzyme. As
shown in Figure 7B in I, caspase-3 (CPP32) is processed proteolytically
from the 32 kDa full-length form into the specific 17 kDa large and 12 kDa
small subunits.  The activation of caspase-3 was noticed to occur at about
8 h after the induction of apoptosis.  If the cells were treated with Z-VAD-
fmk, the processing of caspase-3 was inhibited, indicating a role for
caspase-3 in c-Myc-induced apoptosis.  Further experiments demonstrated
that also caspases-7 (Fig. 1 in IV) and -8 (Fig. 2 and 3 in IV) of the
caspase-3-like subgroup become processed/activated during cell death by
c-Myc.  The kinetics of their activation is approximately similar to that of
caspase-3.  Interestingly, as shown in Figure 7 in II a minor proteolytic
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processing of caspase-9 can be observed only after 48 h following the
induction of c-Myc-induced apoptosis.  In the cell death induced by c-Myc,
caspases-2 (Fig. 7A in I) and -10 (data not shown) were found to remain in
their unprocessed form.
The biological function of caspases is to amplify the apoptotic signals and
to specifically proteolyse their target proteins.  To further study the
involvement of caspases during c-Myc-induced apoptosis, proteins which in
other apoptotic systems and in in vitro-studies have been found out to be
substrates of caspases were studied.  As expected, of the known
substrates of caspases, protein kinase Cd, poly(ADP-ribose) polymerase,
replication factor C, 70 kDa subunit of U1 snRNP, fodrin, Mdm-2, and
lamins B1 and B2, are specifically processed during c-Myc-induced
apoptosis as well (Fig. 5A in I, Fig. 1 and 8 in II), demonstrating that
caspases are indeed involved in the process.  However, not all the
substrates tested become processed indicating that not all cellular proteins
become ubiquitously proteolysed during apoptosis.  The proteolytic
processing of lamins indicates that in addition to caspases-3, -7, and -8
also caspase-6 is active during cell death by c-M c as lamins are known to
be processed by caspase-6 only.  It was not possible to verify this
conclusion in this study, as no rat-reactive antibody against caspase-6 was
available.  Figure 5 summarises the kinetics of the processing of caspases
and cleavage of target proteins during c-Myc-induced apoptosis in Rat
MycER cells (for ATM, cytochrome c, and DYm see later chapters E.2. and
E.3.).
Figure 5.  Kinetics of c-Myc-
induced apoptosis in Rat
MycER cells. Depicted are
processing of caspases and
their substrates,
translocation of cytochrome
c, and loss of mitochondrial
transmembrane potential
(DYm).
ATM
DYm
cytochrome c
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The present study provides data showing that caspases are involved and
necessary for c-Myc-induced apoptosis.  First, if specific caspase inhibitors
are used to prevent the activity of caspases, the cell death induced by c-
Myc is prevented or reduced.  Second, caspases-3, -7 and -8 are shown to
become processed/activated following c-Myc-induced apoptosis.  Third,
many known substrates of caspases get proteolytically processed in a
caspase-specific manner during apoptosis induced by c-Myc.  That the
activation of caspases is not a promiscuous, uncontrolled secondary
consequence of the apoptotic program is supported by the fact that not all
the caspases become activated during c-Myc-induced apoptosis.  Instead,
at least caspases-2 and -10 remain inactive even though they can be
activated for example by caspase-8.
The result of the present study agree with those of Kagaya et al. (1997) and
Juin et al. (1999) showing that caspase inhibitors can prevent cell death by
c-Myc, demonstrating the necessity of the function of caspases in the
process.  Also, it has been argued that whilst the caspase inhibitor is able
to inhibit all other manifestations of apoptosis, it is ineffective against the
plasma membrane blebbing (McCarthy et al. 1997).  It remains possible
that this characteristics of plasma membrane during apoptosis is the result
of effectors other than caspases.  McCarthy et al. (1997) also demonstrate
that eventually (after several days) the cells did undergo apoptosis despite
the caspase inhibitor.  However, because inhibitors are rarely 100%
effective, it remains possible that despite the presence of the inhibitor, a
small portion of the caspase molecules remains active to initiate the
activation of the downstream apoptotic events.
Further support for the importance of caspase action in c-Myc-induced
apoptosis comes from a study indicating that the activity of caspase-9 is
required for an efficient induction of p53-dependent apoptosis by c-Myc
(Soengas et al. 1999).  In the present study, the proteolytic processing of
caspase-9 occurs relatively late (at 48 h).  However, as caspase-9 has
been shown to be active also in its non-processed form (Stennicke et al.
1999), it may mediate the apoptotic signal of c-Myc already in the earlier
phases of the apoptotic process.  In regard to the role of p53, in addition to
Stennicke et al. (1999), the result of another study may indicate that p53 is
required to mediate the apoptotic signal of c-Myc to the level of caspase
activation, as no activation of caspase-1 or -3 was observed in p53-
negative mouse cerebellum cells (Tsunoda et al. 1999).
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E.2.  ATM – a novel substrate of caspases
The ATM protein is a large, multifunctional protein involved in the regulation
of cell cycle progression, DNA repair, meiotic recombination, and
apoptosis.  The absence of wild-type ATM protein is responsible for the
ataxia telangiectasia (AT) -disease with numerous clinical features
including dilated blood vessels, cerebellar degeneration, defects of immune
system, chromosomal aberrations, and predisposition to cancer (Morgan
and Kastan 1997).  AT is a radiation sensitive syndrome in which the
affected cells are extremely sensitive to IR, and fail to arrest in the cell
cycle after IR.  Instead, despite the DNA damage the AT-cells continue in
the cell cycle and eventually die, presumably by apoptosis (Meyn 1995).
Following IR, the AT-cells display an impaired induction of the expression
of p53 and the proteins encoded by p53 target genes (p21, gadd45, Mdm-
2) (Canman et al. 1994; Kastan et al. 1992).  The C-terminus of ATM is
homologous to the kinase domain of DNA-dependent protein kinase.  ATM
is thus a member of the PI3-kinase family (Savitsky et al. 1995), and
consequently it has been shown that ATM can phosphorylate c-Abl
(Baskaran et al. 1997; Shafman et al. 1997), p53 (Banin et al. 1998;
Canman et al. 1998), and Brca1 (Cortez et al. 1999).  Recently, ATM has
been demonstrated to associate with DNA breaks (Smith et al. 1999a;
Suzuki et al. 1999), which causes an increased phosphorylation of p53
(Smith et al. 1999a).
The ATM protein has previously been associated with apoptosis based on
findings in patients with a non-functional ATM protein (AT) (Meyn 1995 and
references therein).  Autopsies of AT-patients have revealed an increased
level of apoptosis in various tissues and AT-cells grown in vitro have an
increased susceptibility to apoptosis. Also, if the expression of ATM is
prevented by an antisense expression of ATM, the viability of cells
decreases following IR (Zhang et al. 1998b).
We noticed that there are several potential cleavage recognition sites for
the different caspases in the amino acid sequence of ATM (Savitsky et al.
1995) and thus it was studied if ATM would be proteolytically processed
during cell death by c-Myc.  As shown in Fig. 2A in II, the 350 kDa full-
length form of ATM does indeed become processed to yield several
proteolytic fragments recognised by the antibody used.  The inhibition of
the activity of caspases by the treatment of cells with Z-VAD-fmk prevented
the cleavage of ATM, demonstrating that ATM is a target of caspase
activity.  In addition to apoptosis induced by c-Myc, ATM became cleaved
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also in staurosporine-induced cell death in the rat fibroblasts and the
leukaemic HL-60 cells (Fig. 2B and 2C in II), indicating that ATM may be a
commonly used target of caspases in various forms of apoptosis.  To
determine which caspase(s) are responsible for the proteolysis of ATM, a
recombinant affinity-purified ATM-protein was incubated with recombinant
caspases-3, -6, -7, or -8.  As shown in Fig. 3A in II, caspases-3 and -7 are
able to cleave ATM, whilst caspases-6 and -8 are not.  Finally, as shown in
Figure 4 in II, ectopic expression of ATM in rat fibroblasts protected cells
from apoptosis, indicating a role for ATM in c-Myc-induced cell death.
Evidence that ATM is a target of caspase-3 has recently been obtained
(Smith et al. 1999b).  The cleavage of human ATM by caspase-3 yields two
fragments, a 100 kDa N-terminal and a 240 kDa C-terminal region, which
after proteolysis remain associated together and retain the ability to bind to
DNA.  However, the processed ATM has a significantly reduced kinase
activity against p53 (Smith et al. 1999b).  It can be envisioned that the
function of full-length ATM is to bind to DNA, and following the appearance
of breaks in DNA ATM would phosphorylate and activate p53 to initiate the
DNA-repair  machinery  (Fig. 6A).   However ,  in  apoptosis (Fig.  6B)  such
Figure 6.
Proposed function of
ATM.  A. Following
damage to DNA,
ATM binds to DNA
breaks and
phosphorylates and
activates p53, which
triggers DNA repair
machinery.  B.
Apoptotic signal
activates caspases,
which proteolyse
their target proteins
(for example,
cleavage of an
inhibitory protein
releases a Caspase
Activated Dnase
[CAD, (Enari et al.
1998)], which digests
DNA).  ATM, a
substrate of caspase-
3, is proteolysed and
is rendered inactive
to phosphorylate and
activate p53.
Inactive p53 does not
activate DNA repair and thus chromatin is further cleaved during progression of apoptosis.
B
ATM
AT M
apoptotic
signal activation
of caspases
cleavage of
substrates
DNA damage
DNA repairp53
DNA damage
A
P DNA repair
p53
p53
ATM
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repair functions would be futile and thus it might be beneficial for the cell to
inactivate ATM by proteolytic cleavage by caspases.  The cleaved ATM
could still bind to DNA but would be unable to activate p53.  (Regarding
p53-dependent apoptosis, it is possible that p53 has already fulfilled its role
in mediating an apoptotic signal by the time ATM is cleaved and its ability to
induce the p53-dependent repair machinery is impaired.)  Thus the role of
ATM may be to function as a molecular sensor of DNA integrity.  In
agreement, a recent study demonstrates that ATM associates with a
histone deacetylase and thus may regulate gene expression and/or
susceptibility to DNA damage (Kim et al. 1999).  In the light of the results by
Smith et al. (1999b), it seems likely that during c-Myc-induced apoptosis
ATM is proteolytically cleaved by caspases in order to inactivate its function
in initiating DNA repair following apoptosis-induced breaks in DNA.
Hypothetically, overexpression of the ATM protein could attenuate
apoptosis initiated by c-Myc if the excess of full-length ATM protein would
temporarily exhaust the caspase(s) responsible for the processing, and if
the apoptotic program could proceed efficiently only when most ATM
molecules would have become cleaved and inactivated.
However, two publications present data contradictory to other studies
mentioned above: the apoptotic responses following telomere shortening
(Karlseder et al. 1999) and g-irradiation during the development of the
nervous system in mice (Herzog et al. 1998) are shown to be dependent on
ATM.  These results would require a model where full-length, functional
ATM would be a necessary mediator of apoptotic signals.
E.3.  Mitochondria and cytochrome c
In numerous apoptotic systems, the loss of the mitochondrial
transmembrane potential (DYm) is an early and irreversible event in the
process of cell death (reviewed in Kroemer et al. 1998).  Thus it was
studied if mitochondria would undergo a change in their transmembrane
potential in c-Myc-induced apoptosis.  As shown in Fig. 3 in II, in about 24 h
after the induction of apoptosis, the mitochondria start to loose their
transmembrane potential.  The treatment of cells with Z-VAD-fmk inhibited
the loss of DYm (Fig. 5 in II) indicating that an upstream caspase(s)
regulates this mitochondrial event.
In several apoptotic situations mitochondrial proteins have been observed
to translocate from mitochondria into the cytoplasm.  It has been
speculated that this translocation would occur via the so-called transition
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pores on the mitochondrial membranes following the loss of DYm (Zamzami
et al. 1995b).  However, as shown in Figure 6 in II, the translocation of
cytochrome c following c-Myc-activity (Juin et al. 1999) occurs earlier (in 8-
16 h) compared to the loss of DYm (in 24 h).  As it has been demonstrated
that the translocation of cytochrome c and other mitochondrial proteins can
occur without the loss of DYm, (Bossy-Wetzel et al. 1998; Kluck et al. 1997;
Vander Heiden et al. 1997; Yang et al. 1997), it seems likely that in rat
fibroblasts the loss of DYm does not contribute significantly to the
cytochrome c-mediated progression of apoptosis induced by c-Myc.
In cytoplasm, cytochrome c becomes associated with caspase-9, Apaf-1,
and dATP, to form the apoptosome complex, which can process and
activate caspase-3 (Li et al. 1997b; Zou et al. 1997). In c-Myc-induced
apoptosis, caspase-9 has been shown to be an important mediator of the
apoptotic program (Soengas et al. 1999).  As mentioned earlier, there is no
apparent processing of caspase-9 in Rat-1 MycERTM cells following c-Myc-
induction until 48 h. As caspase-9 has been shown to be enzymatically
active also in its non-processed form (Stennicke et al. 1999), it is possible
that the unproteolysed caspase-9 mediates the apoptotic signal of c-Myc
from the mitochondria into the activation of the effector caspases (i.e.
caspase-3).
E.4.  Proteins encoded by c-Myc-responsive genes
E.4.1. p53 and its targets
Depending on the study, p53 has been shown either to be needed
(Hermeking and Eick 1994; Soengas et al. 1999; Wagner et al. 1994; Wang
et al. 1993) or not (Lotem and Sachs 1995; Sakamuro et al. 1995) in c-Myc-
induced apoptosis.  The present study demonstrates an increase in the
level of p53 protein expression in about 24 h after the induction of
apoptosis by c-Myc (Fig. 4 in II).
The mechanisms of p53-mediated cell death may include the transcriptional
activation of p53-responsive genes able to regulate apoptosis.  For
example, the gene encoding for Bax, a pro-apoptotic member of the Bcl-2
family, is a target gene of p53 and is thought to be able to mediate the
apoptotic effect of p53 expression (Miyashita and Reed 1995).  p53 can
also decrease the expression of the anti-apoptotic Bcl-2 protein (Miyashita
et al. 1994).  In the present study no changes in the expression levels of
Bcl-2, Bax, Bcl-XL, or Bad were observed within 24 h after c-Myc induction
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(Fig. 3 in I).  This result can not, however, be interpreted as demonstrating
that the Bcl-2 family proteins are not involved in regulating c-Myc-induced
apoptosis, as rather than the level of protein expression, it is the
association of the Bcl-2 proteins to the other members of the family and to
other molecules that is the means of regulation of cell death and survival by
the Bcl-2 proteins.  Thus it remains to be investigated how the anti-
apoptotic Bcl-2 members exert their protective effect on apoptosis induced
by c-Myc (Bissonnette et al. 1992; Fanidi et al. 1992; Reynolds et al. 1994;
Sakamuro et al. 1995; Wagner et al. 1993).  They may regulate the function
of the transition pores thus influencing the DYm or the translocation of
mitochondrial proteins into the cytoplasm.  Also, they may regulate the
activation of the caspase cascade more directly via inhibiting the
processing of caspase-9 by the apoptosome complex.
The gene encoding for the cyclin dependent kinase inhibitor p21 protein is
a target gene of p53 (El-Deiry et al. 1993), and thus the expression pattern
of p21 following c-Myc-induced apoptosis was studied.  As expected, the
level of p21 protein expression increased 24 h after the induction of c-Myc
activity and the subsequent increase in p53 expression (Fig. 8 in II).
However, as p21 has been shown to be involved primarily in the arrest of
cell proliferation and not in apoptosis (Brugarolas et al. 1995; Caelles et al.
1994; Wagner et al. 1994), it is likely that p21 is not a mediator of c-Myc-
induced apoptosis, but responds to the increased level of p53 in a manner
unrelated to apoptosis.
p53 activates the transcriptional expression of Mdm-2 protein, which
negatively regulates the expression of p53 by promoting its degradation
(Haupt et al. 1997; Honda et al. 1997; Kubbutat et al. 1997).  According to
the results of present study, the expression of Mdm-2 increases at 24 h
(Fig. 8 in II), most likely due to transactivation by p53.  However, at a later
time point Mdm-2 begins to be proteolytically processed.  As Mdm-2 is an
in vitro substrate of caspases-3, -6, and -7 (Erhardt et al. 1997), which
become activated also during c-Myc-induced apoptosis, it is likely that
Mdm-2 becomes cleaved by one or several of these caspases in c-Myc-
induced cell death.
Regarding the role of p53 in c-Myc-induced apoptosis, there is no
agreement presently whether p53 is required or not.  The present study
shows that an increase at the level of p53 protein expression occurs at 24 h
after the induction of c-Myc activity.  At this time, the cells already exhibit
several apoptotic changes: caspases are active (Fig. 7 in I, Fig. 1 and 2 in
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IV) and several of their substrates are processed (Fig. 1 in II), mitochondrial
transmembrane is decreasing (Fig. 5 in II), plasma membrane has
undergone major changes (as judged by the externalization of
phosphatidylserines and binding of AnnexinV [Fig. 6A in I], cells are
detached from the substratum, and Trypan blue dye permeability is
increased [Fig. 6B in I]).  It is possible that the increase of p53 protein
expression at this later time point (24 h) is a secondary consequence of the
appearance of breaks in the DNA during apoptosis instead of being
required to mediate the apoptotic signal.  However, as the physiological
activity of p53 is regulated by various other means in addition to the level of
its protein expression, it is possible that p53 is required to mediate the
apoptotic signal of c-Myc, for example at an earlier phase(s) of apoptosis.
In support of this, in mouse embryo fibroblasts p53 has been shown to
mediate c-Myc-induced apoptosis to the level of caspase-9 activation
(Soengas et al. 1999).
E.4.2.  Cyclin A
Cyclin A regulates the progression of cell cycle in the S-phase and its
expression has been shown to be increased by c-Myc (Jansen-Durr et al.
1993).  A study demonstrates that an increased expression of cyclin A is
able to cause apoptosis (Hoang et al. 1994), but another study indicates
that cyclins are not required for the ability of c-Myc to promote apoptosis
(Rudolph et al. 1996).  In the present study, no significant changes in the
expression levels of any of the cyclins studied were observed during c-Myc-
induced apoptosis (Fig. 4 in I).
E.4.3.  Odc
odc has several sites for c-Myc-binding and the present study confirms the
results by Bello-Fernandez et al. demonstrating that c-Myc does
transactivate odc (Fig. 1 in III; Bello-Fernandez et al. 1993).  When cells
grow in high serum concentration, the transcription of odc is induced with
increasing amounts of c-Myc protein (Fig. 1B in III).  Interestingly, in low
serum the initial induction of odc transcription with small amount of c-Myc
protein is reduced with higher levels of c-Myc expression (Fig. 1A in III).
The same effect was shown at the level of odc mRNA following c-Myc
expression: in high serum the level of odc mRNA expression increases
following c-Myc induction, but in low serum there is no marked increase in
odc mRNA due to c-Myc activity (Fig. 1 in Appendix).  As c-Myc can have
an apoptotic effect, it was investigated if the absence of induction of odc
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expression in low serum could be a consequence of apoptosis induced by
c-Myc.  Indeed, as the effect of the expression of c-Myc on the cells was
investigated, it was noticed that the level of apoptosis increased with
increasing amounts of c-Myc (Fig. 2 in Appendix).  Thus it seems that in
serum, there are factors which determine the response of cells to an
elevated level of c-Myc expression.  In low serum the cells die due to
apoptosis, but in high serum the cells can proliferate (for which the activity
of Odc is required).  In support for this, Harrington et al. have shown that
cytokines can have a protective effect on c-Myc-induced apoptosis
(Harrington et al. 1994).
In mouse myeloid cells, Odc been shown to be a mediator of cell death by
c-Myc (Packham and Cleveland 1994).  Thus it was examined if Odc would
be a mediator of c-Myc-induced apoptosis in rat fibroblasts.  However,
when the enzymatic activity of Odc was inhibited by the specific inhibitor
DFMO, there was no decrease in the level of apoptosis induced by c-Myc
activity (Fig. 1B in I) indicating that the enzymatic activity of Odc is not
required for c-Myc-induced cell death in rat fibroblasts.  It may be possible
that the discrepancy of our results and the ones by Packham and
Cleveland, and the effects of changes in polyamine contents on apoptosis
in various systems (Brune et al. 1991; Desiderio et al. 1995; Grassilli et al.
1995; Hu and Pegg 1997; Poulin et al. 1995; Tobias and Kahana 1995),
reflects a differential requirement of factors in apoptosis between
lymphocytic and fibroblastic cells.
E.4.4. TNFR and FADD
A report demonstrates that Fas is required for c-Myc-induced apoptosis and
that FADD, an adapter protein mediating the association between
Fas/TNFR and caspase-8, is necessary for the apoptotic process in mouse
fibroblasts (Hueber et al. 1997).  It has also been postulated that FADD
may mediate c-Myc-induced apoptosis downstream of some other molecule
different from Fas (Rohn et al. 1998).  Also, data indicates that FADD would
exert its effect on c-Myc-induced apoptosis downstream of cytoplasmic
cytochrome c (Juin et al. 1999).  Contradictory to the previous studies, Y h
et al. (1998) show that cells from a mouse without expression of FADD
protein are not impaired in apoptosis induced by c-Myc.
Thus the involvement of TNFR and FADD in c-Myc-induced apoptosis in rat
fibroblasts was investigated.  It was tested if the inhibition of the activation
of TNFR would have an effect on the activation of caspases and apoptosis
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induced by c-Myc.  By using neutralising antibodies against TNFa the
signalling by TNF-R was inhibited, but no effect either on the level of cell
death (Fig. 4 in IV) or cleavage of caspase-8 (Fig. 5 in IV) was observed
following the induction of c-Myc activity and apoptosis.  Thus it is possible
to conclude that signalling by TNFR-pathway is not required for apoptosis
or the activation of caspase-8 in c-Myc-induced cell death in rat fibroblasts.
Further, the involvement of FADD in the activation of caspases and cell
death by c-Myc was studied.  A gene construct encoding for a fusion
protein with dominant-negative FADD protein and Green Fluorescent
Protein (GFP) was transfected into the Rat-1 MycERTM cells.  After the cells
were grown for 36 h, a subpopulation of cells expressing a high level of
GFP (less than 1% of the cells) was selected by FACS.  However, these
cells were not able to sustain growth (data not shown).  This may be due to
a negative effect of a high degree of inhibition of FADD on the proliferation
of the cells, a phenomenon observed earlier in lymphocytic cells (Newton et
al. 1998; Walsh et al. 1998; Yeh et al. 1998; Zhang et al. 1998a; Zornig et
al. 1998).  When the Rat-1 MycERTM cells were again transfected with the
same plasmid construct and the level of apoptosis by c-Myc was
determined without selection for cells with high expression levels of DN-
FADD, a minor decrease on the percentage of apoptotic cells was detected
(data not shown).  Also in this experiment there was a decrease in the total
number of cells.  Thus it is possible that FADD has a dual function in
fibroblastic cells: it is required for proliferation and is involved in apoptosis
by Fas, but is not directly involved in apoptosis induced by c-Myc.
F.  Concluding remarks
This study has provided evidence to demonstrate that caspases are
centrally involved in mediating the apoptotic effect of c-Myc in rat fibroblast
cells. Specifically, caspases-3, -6, -7, -8, and -9 become processed/
activated during apoptosis induced by c-Myc.  The importance of caspase
action is underlined by the observation that an inhibition of caspase activity
attenuates the apoptotic process.  The present study shows that ATM is a
novel target protein of caspases and that caspases-3 and -7 can proteolyse
ATM in vitro.  The role of caspases is further evidenced by the
demonstration of specific cleavages of a number of previously identified
substrates of caspases upon c-Myc induction.  Also, the translocation of
mitochondrial cytochrome c into the cytoplasm  is  demonstrated  to  be  an
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Figure 7.  Molecular mechanisms of apoptosis induced by increased c-Myc activity.
Activation of c-Myc leads into activation of caspases-3, -6, -7, -8, and –9 via unknown
mechanism.  They act by cleaving cellular substrates (e.g. ATM) which causes demise of
the cell.  c-Myc-induced apoptosis has been proposed to require activation of Fas-receptor
and to be mediated by FADD.  Mitochondrial activities (loss of transmembrane potential,
translocation of proteins [eg. cytochrome c]) are regulated by Bcl-2 family members and
amplify apoptotic signal and activate caspase-9.  Survival factors prevent apoptosis by
activating Akt-kinase pathway, which phosphorylates and inactivates caspase-9 and pro-
apoptotic Bcl-2-member Bad.  Apoptosis induced by c-Myc may be mediated or augmented
by p53, in part via increased expression of p19Arf by c-Myc.  Uncontinuous arrow lines
represent indirect pathways.
family
e.g. ATM
pathway
mitoc.
?
Ldh-A
AP-2
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early event during c-Myc-induced cell death.  Evidence is also provided that
shows that the activation of TNFR by ligand binding is not needed for the
ability of c-Myc to induce apoptosis.  This data is depicted and summarised
in Figure 7 in relation to the previously suggested molecules and
mechanisms involved in mediating and regulating the process of apoptosis
induced by an increased c-Myc activity.  In short, indicated are the possible
role of p53 regulated by c-Myc-responsive p19Arf- rotein and the
mitochondrial events regulated by the members of Bcl-2-family.  At the
plasma membrane, death receptors may signal to activate caspase-8 via
the adaptor protein FADD.  Countering this, receptors for survival factors
may initiate a signalling pathway leading into the activation of Akt-kinase,
which prevents apoptosis by phosphorylating and inactivating caspase-9
and Bad.
Finally, it still remains elusive what are the events and molecules involved
in mediating the early apoptotic signal(s) of c-Myc to the level of caspase
activation.  The initiation of caspase cascade activation could start by
signalling via a death receptor at the plasma membrane, which would lead
into the activation of caspase-8.  Or mitochondrial events could initiate the
caspase cascade by activating caspase-9 leading into the activation of
caspase-3, which can further activate caspase-8.  Future studies will be
needed to elucidate the mechanism(s) of c-Myc-induced apoptosis to more
detail, and explain how c-Myc can promote both cell growth and cell death
and what are the factors influencing that decision.
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